Page 4 - Remunity Pump News Today

Krensavage Asset Management LLC lowered its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 0.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 201,222 shares of the biotechnology company’s stock after selling 1,493 shares during the period. […]

Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been assigned a consensus rating of “Buy” from the eight ratings firms that are covering the firm, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have issued a report on the […]

StockNews.com upgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a buy rating to a strong-buy rating in a research note released on Friday morning. Several other research firms also recently weighed in on UTHR. Wedbush reaffirmed an outperform rating and issued a $308.00 price objective (up previously from $307.00) on shares of United […]

Equities researchers at Wells Fargo & Company started coverage on shares of United Therapeutics (NASDAQ:UTHR – Get Free Report) in a research note issued on Friday, Briefing.com reports. The brokerage set an “overweight” rating and a $309.00 price target on the biotechnology company’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside […]

PDT Partners LLC grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 46.0% during the second quarter, according to its most recent filing with the SEC. The firm owned 17,617 shares of the biotechnology company’s stock after acquiring an additional 5,548 shares during the period. PDT Partners LLC’s holdings in […]

Seaport Global Advisors LLC grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 20.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,545 shares of the biotechnology company’s stock after buying an additional 438 shares […]

Seaport Global Advisors LLC increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 20.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,545 shares of the biotechnology company’s stock after buying an additional 438 shares during […]

Retirement Investment Advisors Inc. acquired a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,200 shares of the biotechnology company’s stock, valued at approximately $265,000. Other large investors […]

Tiziana Life Sciences (NASDAQ:TLSA – Get Free Report) and United Therapeutics (NASDAQ:UTHR – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Institutional and Insider Ownership 0.9% of Tiziana […]

United Therapeutics (NASDAQ:UTHR – Get Free Report) and Tiziana Life Sciences (NASDAQ:TLSA – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends. Institutional & Insider Ownership 94.1% of United […]